Galvin, Gaustad & Stein, LLC
Source: SEC Form 13F · as of Mar 2026Galvin, Gaustad & Stein, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $51.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$51.7M
| Company | Shares | Value |
|---|---|---|
| VRTXVERTEX PHARMACEUTICALS INC / MA | 35,233 | $15.7M |
| GEHCGE HealthCare Technologies Inc. | 182,097 | $13.0M |
| ZTSZoetis Inc. | 86,985 | $10.3M |
| JNJJOHNSON & JOHNSON | 16,834 | $4.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,950 | $1.6M |
| PMPhilip Morris International Inc | 8,256 | $1.4M |
| ABBVAbbVie Inc. | 5,864 | $1.3M |
| LLYELI LILLY & Co | 1,324 | $1.2M |
| DGXQuest Diagnostics Incorporated | 4,332 | $849K |
| AMGNAMGEN INC | 2,042 | $719K |
| MRKMerck & Co., Inc. | 5,186 | $624K |
| MCKMcKesson Corporation | 574 | $497K |
| SHCSotera Health Company | 29,107 | $417K |
| TNYATenaya Therapeutics, Inc. | 11,000 | $8K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.